MedPath

Efficacy and Safety of a New Sperm Capacitation Method

Not yet recruiting
Conditions
Reproductive Issues
Male Infertility
Asthenozoospermia
Oligozoospermia
Teratozoospermia
Registration Number
NCT06742437
Lead Sponsor
Fecundis Lab SL
Brief Summary

Prospective, multicenter research study with a split-sample design on semen samples, without intervention, to evaluate the efficacy and safety of HyperSperm, a new sperm capacitation method, in 300 semen samples with various characteristics and abnormalities, in an in vitro study over 12 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Male
Target Recruitment
300
Inclusion Criteria
  • Ability to provide a semen sample via masturbation
Read More
Exclusion Criteria
  • Current diagnosis of a sexually transmitted infection (STI)
  • Previous diagnosis of hepatitis A, B, C, D, or HIV
  • Prior participation in this study
  • Participation in a clinical trial involving an intervention within the last 3 months
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hyperactivation2 hours

Percentage of sperm cells displaying hyperactivated motility

Secondary Outcome Measures
NameTimeMethod
Sperm vitality2 hours

Percentage of viable sperm cells

DNA fragmentation2 hours

Percentage of TUNEL-positive sperm cells

Sperm motility2 hours

Percentage of motile sperm cells

Survival20 hours

Percentage of motile sperm cells after overnight incubation

Trial Locations

Locations (4)

Eugin Barcelona

🇪🇸

Barcelona, Spain

Fertty

🇪🇸

Barcelona, Spain

CIRH

🇪🇸

Barcelona, Spain

Natuvitro

🇪🇸

Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath